Trial Details
Not RecruitingBasic Information
| Clinical ID | c3012 |
|---|---|
| Identifier | NL-OMON42112 |
| Trial Title | Identification of microbiota-specific mucosal immune responses driving primary sclerosing cholangitis (PSC) and concomitant inflammatory bowel disease (IBD)._ - Understanding PSC-IBD |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | inflammatory bowel disease with bile duct and/or liver disease;10017969;10019654;inflammatory bowel disease with bile duct and/or liver disease |
| Interventions | ;Inflammatory bowel disease;Microbiota-specific immune responses;Mucosal T-cells;Primary sclerosing cholangitis |
Participant Information
| Sponsor | Erasmus MC, Universitair Medisch Centrum Rotterdam |
|---|---|
| City | - |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | ADULT, CHILD, TEENAGER |
Study Design
| Study Type | Observational invasive |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |